Article
N-acetyltransferase polymorphism in patients with Behçet's disease.
European journal of clinical pharmacology - 1 Nov 2001
Aynacioglu A S, Bozkurt A, Nacak M, Kortunay S, Tunc R, Dincel A, Kayaalp S O
Abstract excerpt
OBJECTIVES: The objective of our study was to investigate the possible role of human arylamine N-acetyltransferase 2 (NAT2) polymorphism in susceptibility to Behçet's disease. METHODS: Eighty-five patients with Behçet's disease gave their written informed consent to participate in the study. Seven point mutations (G191A, C282T, T341C, C481T, A803G, G590A, G857A) in the NAT2 gene were analysed using polymerase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
